← Back to Search

Other

Bipolar Disorder for Bipolar Disorder (BIPO Trial)

N/A
Waitlist Available
Led By Nicolaas Bohnen, MD
Research Sponsored by University of Michigan
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up after 90 +/- 10 days of intervention
Awards & highlights

BIPO Trial Summary

"This trial is looking at whether a supplement called Juvenescence, combined with a diet that mimics the effects of the ketogenic diet, could help people with bipolar disorder. It is a small study

BIPO Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~after 90 +/- 10 days of intervention
This trial's timeline: 3 weeks for screening, Varies for treatment, and after 90 +/- 10 days of intervention for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in blood beta-hydroxybutyrate level
Secondary outcome measures
Change in blood glucose lability
Change in neural network stability

BIPO Trial Design

1Treatment groups
Experimental Treatment
Group I: Bipolar DisorderExperimental Treatment2 Interventions
Participants will follow an intervention consisting of dietary changes and ketone ester supplementation for 90 +/- 10 days. The dietary changes are intended to reduce glycemic spiking and include: not consuming sweets, not consuming soda, replacing 'white' grains with whole grain alternatives, and reserving any fruit consumption for the end of meals. During the same time period, participants will consume the ketone ester supplement, consisting of 19 g Juvenescence Cognitive Switch™ (=12.5 g active C8-KE) diluted in water twice per day.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Low Glycemic Index Diet
2014
N/A
~290

Find a Location

Who is running the clinical trial?

University of MichiganLead Sponsor
1,799 Previous Clinical Trials
6,378,626 Total Patients Enrolled
19 Trials studying Bipolar Disorder
3,200 Patients Enrolled for Bipolar Disorder
Nicolaas Bohnen, MDPrincipal InvestigatorUniversity of Michigan
2 Previous Clinical Trials
30 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any available openings for participants in this ongoing medical study?

"According to the data available on clinicaltrials.gov, this specific research investigation is not presently seeking participants. Although first listed on March 1st, 2024 and last updated on March 21st, 2024, it is important to note that there are currently 174 alternative studies actively enrolling volunteers."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Brain Small Chain Fatty Acid Metabolism in Bipolar Disorder: Ketones
Nicolaas Bohnen, MD, PhD 2024. "Brain Small Chain Fatty Acid Metabolism in Bipolar Disorder: Ketones". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06335875.
All > Bipolar Disorder
~8 spots leftby Mar 2027
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top